Exane Derivatives’s Ultrapar UGP Stock Holding History

Exane Derivatives’s Portfolio UGP Stock Details UGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-148,000	Closed	-$506K	–	866
2020 Q3	$506K	Buy	148,000 +13,366	+10%	+$49.2K	0.15%	130
2020 Q2	$456K	Sell	134,634 -137,577	-51%	-$405K	0.12%	148
2020 Q1	$661K	Sell	272,211 -134,210	-33%	-$644K	0.18%	102
2019 Q4	$2.46M	Buy	406,421 +21,840	+6%	+$111K	0.46%	71
2019 Q3	$1.72M	Buy	384,581 +110,000	+40%	+$518K	0.31%	76
2019 Q2	$1.44M	Buy	274,581 +189,021	+221%	+$1.03M	0.25%	81
2019 Q1	$511K	Buy	+85,560	New	+$608K	0.1%	153
2015 Q3	–	Sell	-788	Closed	-$8.28K	–	573
2015 Q2	$8.28K	Hold	788	–	–	﹤0.01%	373
2015 Q1	$7.96K	Sell	788 -1,374	-64%	-$13.4K	﹤0.01%	392
2014 Q4	$20.6K	Buy	+2,162	New	+$21.8K	﹤0.01%	386

Other funds holding UGP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SGDR

SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Derivatives's UGP Position: Q4 2020 in Review

Exane Derivatives sold out of Ultrapar (UGP) in Q4 2020, closing a stake of 148,000 shares — an estimated $506K sold.

Exane Derivatives first reported a position in UGP in Q4 2014 and held it in 10 quarters. The position peaked at $2.46M in Q4 2019. 84 funds tracked by Wall St. Rank hold UGP as of Q4 2020.

Exane Derivatives reported no remaining Ultrapar position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 148,000 Ultrapar shares in Q4 2020, an estimated $506K.
Exane Derivatives first reported a position in Ultrapar in Q4 2014 and held it in 10 quarters.
Exane Derivatives's Ultrapar position peaked at $2.46M in Q4 2019.
84 funds tracked by Wall St. Rank held Ultrapar as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.